Design, Synthesis, and Preliminary Investigation on the Mode of Action for a Series of Novel Antimicrobial Peptidomimetics
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.6c01445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Diletta Bergamo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124Parma, Italy. Hauptthemen laut MEDLINE: Peptidomimetics, Drug Design, Antimicrobial Peptides, Anti-Bacterial Agents. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centro, Centro Interdipartimentale Misure G. Casnati.
Abstract (Originalsprache)
Over the years, many antibiotics have been developed, but most have become less effective due to antimicrobial resistance, especially those targeting enzymatic pathways. This growing resistance poses a serious global health threat. It is now recognized that physically disrupting bacterial cell membranes is less prone to resistance development. Antimicrobial peptides (AMPs) are promising in this regard, though their broader application is limited by their susceptibility to proteolytic degradation and toxicity. To address these issues, peptidomimetics have emerged as a new class of antibacterial agents. In this study, a library of AMPs were designed and synthesized, inspired by magainin, a defensin-mimetic molecule, and brilacidin. Modifying side chain lengths proved essential for effective insertion into phospholipid bilayers. A modular synthetic approach was developed, enabling the generation of diverse derivatives to explore structure−activity relationships. The compounds were tested against clinically relevant pathogens, showing promising antimicrobial activity, and preliminary studies confirmed a membranolytic mechanism of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124Parma, Italy.
- Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Germany-Helmholtz Centre for Infection Research (HZI), Campus E8.1, 66123Saarbrücken, Germany.
- Central Facility for Microscopy, Helmholtz Centre for Infection Research, Braunschweig38124, Germany.
- German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Inhoffenstraße 7, 38124Braunschweig, Germany.
- PharmaScienceHub (PSH), Saarland University, Campus E8.1, 66123Saarbrücken, Germany.
- Department of Pharmacy, Saarland University, Campus C4.3, 66123Saarbrücken, Germany.
ORCID-Profile: Giannamaria Annunziato, Anna K H Hirsch, Rolf Müller, Marco Pieroni
Förderung
- Centro
- Centro Interdipartimentale Misure G. Casnati
Zitieren
APA
Bergamo, D., Cirnski, K., Müsken, M., Annunziato, G., Jézéquel, G., Hirsch, A. K. H., Costantino, G., Müller, R., & Pieroni, M. (2026). Design, Synthesis, and Preliminary Investigation on the Mode of Action for a Series of Novel Antimicrobial Peptidomimetics. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01445
Vancouver
Bergamo D, Cirnski K, Müsken M, Annunziato G, Jézéquel G, Hirsch AKH, et al. Design, Synthesis, and Preliminary Investigation on the Mode of Action for a Series of Novel Antimicrobial Peptidomimetics. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01445
BibTeX
@article{Bergamo2026,
author = {Bergamo, Diletta and Cirnski, Katarina and Müsken, Mathias and Annunziato, Giannamaria and Jézéquel, Gwenaëlle and Hirsch, Anna K H and Costantino, Gabriele and Müller, Rolf and Pieroni, Marco},
title = {Design, Synthesis, and Preliminary Investigation on the Mode of Action for a Series of Novel Antimicrobial Peptidomimetics},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c01445}
}
EUVIMED